Rituximab therapy prevents focal and segmental glomerulosclerosis recurrence after a second renal transplantation - PubMed

Case Reports

Rituximab therapy prevents focal and segmental glomerulosclerosis recurrence after a second renal transplantation

Vincent Audard et al. Transpl Int. 2012 May.

Free article

Abstract

Preventive treatment of focal and segmental glomerulosclerosis (FSGS) allograft recurrence in high risk recipients having a prior history of graft loss caused by FSGS recurrence is still a challenging question. We retrospectively identified four patients who underwent a second renal transplantation because of recurrent FSGS and who received Rituximab therapy as a prophylactic treatment. Loss of their first allograft was directly related to an early (<3 months) recurrence of FSGS that was either resistant to plasmapheresis therapy in two cases or had escaped to this therapeutic management in the two others. After the second renal transplantation, all patients were free of FSGS recurrence during follow-ups that were between 12 and 54 months long. These preliminary results demonstrate for the first time that Rituximab therapy may constitute an attractive prophylactic option for patients being considered for a second renal transplantation because of recurrent FSGS in their first graft.

Similar articles

• Combination treatment with plasmapheresis and rituximab for recurrent focal segmental glomerulosclerosis after renal transplantation.

  Tsagalis G, Psimenou E, Nakopoulou L, Laggouranis A. Tsagalis G, et al. Artif Organs. 2011 Apr;35(4):420-5. doi: 10.1111/j.1525-1594.2010.01068.x. Artif Organs. 2011. PMID: 20637013

• Rituximab and chronic plasmapheresis therapy of nephrotic syndrome in renal transplantation patients with recurrent focal segmental glomerulosclerosis.

  Rodríguez-Ferrero M, Ampuero J, Anaya F. Rodríguez-Ferrero M, et al. Transplant Proc. 2009 Jul-Aug;41(6):2406-8. doi: 10.1016/j.transproceed.2009.06.044. Transplant Proc. 2009. PMID: 19715934

• Pretransplantation combined therapy with plasmapheresis and rituximab in a second living-related kidney transplant pediatric recipient with a very high risk for focal segmental glomerulosclerosis recurrence.

  Chikamoto H, Hattori M, Kuroda N, Kajiho Y, Matsumura H, Fujii H, Ishizuka K, Hisano M, Akioka Y, Nozu K, Kaito H, Shimizu M. Chikamoto H, et al. Pediatr Transplant. 2012 Nov;16(7):E286-90. doi: 10.1111/j.1399-3046.2011.01610.x. Epub 2011 Nov 30. Pediatr Transplant. 2012. PMID: 22129369

• Recurrence of focal segmental glomerulosclerosis in renal allograft: an in-depth review.

  Vinai M, Waber P, Seikaly MG. Vinai M, et al. Pediatr Transplant. 2010 May;14(3):314-25. doi: 10.1111/j.1399-3046.2009.01261.x. Pediatr Transplant. 2010. PMID: 20519016 Review.

• Focal segmental glomerulosclerosis and renal transplantation.

  Crosson JT. Crosson JT. Transplant Proc. 2007 Apr;39(3):737-43. doi: 10.1016/j.transproceed.2007.02.010. Transplant Proc. 2007. PMID: 17445586 Review.

Cited by

• Urine but not serum soluble urokinase receptor (suPAR) may identify cases of recurrent FSGS in kidney transplant candidates.

  Franco Palacios CR, Lieske JC, Wadei HM, Rule AD, Fervenza FC, Voskoboev N, Garovic VD, Zand L, Stegall MD, Cosio FG, Amer H. Franco Palacios CR, et al. Transplantation. 2013 Aug 27;96(4):394-9. doi: 10.1097/TP.0b013e3182977ab1. Transplantation. 2013. PMID: 23736353 Free PMC article.

• Rituximab therapy in nephrotic syndrome: implications for patients' management.

  Sinha A, Bagga A. Sinha A, et al. Nat Rev Nephrol. 2013 Mar;9(3):154-69. doi: 10.1038/nrneph.2012.289. Epub 2013 Jan 22. Nat Rev Nephrol. 2013. PMID: 23338210 Review.

• Update on the treatment of focal segmental glomerulosclerosis in renal transplantation.

  Messina M, Gallo E, Mella A, Pagani F, Biancone L. Messina M, et al. World J Transplant. 2016 Mar 24;6(1):54-68. doi: 10.5500/wjt.v6.i1.54. World J Transplant. 2016. PMID: 27011905 Free PMC article. Review.

• Rituximab and Therapeutic Plasma Exchange in Recurrent Focal Segmental Glomerulosclerosis Postkidney Transplantation.

  Alasfar S, Matar D, Montgomery RA, Desai N, Lonze B, Vujjini V, Estrella MM, Manllo Dieck J, Khneizer G, Sever S, Reiser J, Alachkar N. Alasfar S, et al. Transplantation. 2018 Mar;102(3):e115-e120. doi: 10.1097/TP.0000000000002008. Transplantation. 2018. PMID: 29189487 Free PMC article.

• Optimal management of primary focal segmental glomerulosclerosis in adults.

  Beaudreuil S, Lorenzo HK, Elias M, Nnang Obada E, Charpentier B, Durrbach A. Beaudreuil S, et al. Int J Nephrol Renovasc Dis. 2017 May 10;10:97-107. doi: 10.2147/IJNRD.S126844. eCollection 2017. Int J Nephrol Renovasc Dis. 2017. PMID: 28546764 Free PMC article. Review.

Publication types

MeSH terms

Substances

LinkOut - more resources

• Full Text Sources

  • Wiley

• Medical

  • MedlinePlus Health Information